Literature DB >> 17413556

Bridge to lung transplantation with the extracorporeal membrane ventilator Novalung in the veno-venous mode: the initial Hannover experience.

Stefan Fischer1, Marius M Hoeper, Sandra Tomaszek, Andre Simon, Jens Gottlieb, Tobias Welte, Axel Haverich, Martin Strueber.   

Abstract

Conventional extracorporeal membrane oxygenation and mechanical ventilation have both been identified as significant risk factors for post-lung transplant mortality when applied as a bridge to lung transplantation. We have previously described the successful use of the extracorporeal membrane ventilator Novalung as a bridge to lung transplantation in patients with severe hypercapnia and respiratory acidosis. In this setting the Novalung was connected in the arterio-venous mode without support of a mechanical blood pump. However, in patients with predominant hypoxemia, this pumpless mode does not achieve sufficient blood oxygenation due to limited blood flow. Thus, such patients require pump-driven support. Here we describe our initial experience with the Novalung extracorporeal membrane ventilator, which was originally designed for pumpless carbon dioxide removal, as a bridge to lung transplantation in patients with ventilator-refractory hypoxemia in the veno-venous pump-driven mode.

Entities:  

Mesh:

Year:  2007        PMID: 17413556     DOI: 10.1097/MAT.0b013e31802deb46

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  9 in total

1.  Biocompatibility Assessment of the CentriMag-Novalung Adult ECMO Circuit in a Model of Acute Pulmonary Hypertension.

Authors:  Venkat Shankarraman; Ergin Kocyildirim; Salim E Olia; Marina V Kameneva; Ryan J Dzadony; Timothy M Maul; Marc A Simon; Hunter C Champion; William R Wagner; Christian A Bermudez
Journal:  ASAIO J       Date:  2014 Jul-Aug       Impact factor: 2.872

2.  Gas Transfer in Cellularized Collagen-Membrane Gas Exchange Devices.

Authors:  Justin H Lo; Erik K Bassett; Elliot J N Penson; David M Hoganson; Joseph P Vacanti
Journal:  Tissue Eng Part A       Date:  2015-07-16       Impact factor: 3.845

Review 3.  Current clinical management of pulmonary arterial hypertension.

Authors:  Roham T Zamanian; Kristina T Kudelko; Yon K Sung; Vinicio de Jesus Perez; Juliana Liu; Edda Spiekerkoetter
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

4.  Extracorporeal life support for management of refractory cardiac or respiratory failure: initial experience in a tertiary centre.

Authors:  Adriano Peris; Giovanni Cianchi; Simona Biondi; Manuela Bonizzoli; Andrea Pasquini; Massimo Bonacchi; Marco Ciapetti; Giovanni Zagli; Simona Bacci; Chiara Lazzeri; Pasquale Bernardo; Erminia Mascitelli; Guido Sani; Gian Franco Gensini
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2010-05-21       Impact factor: 2.953

Review 5.  Coming to terms with tissue engineering and regenerative medicine in the lung.

Authors:  Y S Prakash; Daniel J Tschumperlin; Kurt R Stenmark
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-08-07       Impact factor: 5.464

Review 6.  [The place of extra-corporeal oxygenation in pulmonary diseases].

Authors:  M Le Guen; F Parquin
Journal:  Rev Mal Respir       Date:  2014-10-30       Impact factor: 0.622

7.  First in vivo assessment of RAS-Q technology as lung support device for pulmonary hypertension.

Authors:  Tom Verbelen; Michael Halwes; Bart Meyns
Journal:  Int J Artif Organs       Date:  2020-09-10       Impact factor: 1.595

Review 8.  Extracorporeal life support devices and strategies for management of acute cardiorespiratory failure in adult patients: a comprehensive review.

Authors:  Kiran Shekar; Daniel V Mullany; Bruce Thomson; Marc Ziegenfuss; David G Platts; John F Fraser
Journal:  Crit Care       Date:  2014-05-09       Impact factor: 9.097

Review 9.  Bioengineering Progress in Lung Assist Devices.

Authors:  Ahad Syed; Sarah Kerdi; Adnan Qamar
Journal:  Bioengineering (Basel)       Date:  2021-06-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.